Beranda › Leukemia › Illinois › Chicago
Uji klinis Leukemia di Chicago, IL
16 studi untuk Leukemia mencari peserta di lokasi sekitar Chicago (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Menerima pesertaFase 1/2
- The University of Chicago Medical Center, Chicago
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
Menerima pesertaFase 3
- Research Site, Chicago
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
Menerima pesertaFase 1/2
- University of Chicago, Chicago
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Menerima pesertaFase 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Menerima pesertaFase 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Menerima pesertaFase 1/2
- Research Site, Chicago
Mosaic Trial for Stem Cell Transplant Recipients
Menerima peserta
- Northwestern University Feinberg School of Medicine, Chicago
Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)
Menerima pesertaFase 2
- University of Chicago Medical Center, Chicago
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Menerima pesertaStudi observasional
- Lurie Children's Hospital-Chicago, Chicago
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Menerima pesertaFase 1/2
- University of Illinois at Chicago Cancer Center, Chicago
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Menerima pesertaFase 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL
Menerima pesertaFase 1/2
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia
Menerima peserta
- UChicago Medicine Comprehensive Cancer Center, Chicago
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Menerima peserta
- University of Chicago Comprehensive Cancer Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Chicago
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Menerima pesertaFase 1
- Northwestern Medicine - Northwestern Memorial Hospital Galter Pavilion, Chicago
Uji klinis Leukemia di kota lain
- Houston, TX28 studi
- Boston, MA25 studi
- New York City, NY19 studi
- Los Angeles, CA16 studi
- Durham, NC13 studi
- Columbus, OH12 studi
- Nashville, TN12 studi
- Baldwin Park, CA12 studi
- Philadelphia, PA12 studi
- Atlanta, GA11 studi
- Seattle, WA11 studi
- Milwaukee, WI11 studi
Studi lain di Chicago
- Kanker Paru Non-Sel Kecil61 studi
- Kanker Payudara58 studi
- Kanker (semua jenis)51 studi
- Kanker Prostat45 studi
- Kanker Metastatik45 studi
- Obesitas42 studi
- Kanker Paru41 studi
- Kanker Ovarium36 studi
- Stroke34 studi
- Kanker Kolorektal32 studi
- Gagal Jantung31 studi
- Kelebihan Berat Badan28 studi
Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.